Key facts
- Roth/MKM initiated coverage of Coya Therapeutics stock.
- Roth/MKM assigned a buy rating to Coya Therapeutics stock.
- Roth/MKM set a target price for Coya Therapeutics shares.
Roth/MKM has begun covering Coya Therapeutics, assigning a 'buy' rating to the company's stock. The brokerage firm also established a specific price target for Coya Therapeutics' shares, indicating a positive outlook on the company's future performance.